Medical News

RSS

Increased doses of erlotinib drug may lead to better outcomes in lung cancer patients

Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases.

12 Jan 2010

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

A study recently conducted by US Oncology and Aetna finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway’) to those treated with non-evidence-based guidelines (also known as ‘off pathway’), was published in the peer-reviewed Journal of Oncology Practice.

12 Jan 2010

Richard N. Zare to receive the 2010 TWR Medal for Conspicuous Achievement in Chemistry

Richard N. Zare, the Marguerite Blake Wilbur Professor in Natural Science at Stanford University has been selected to receive the 2010 Theodore William Richards (TWR) Medal for Conspicuous Achievement in Chemistry from the Northeastern Section of the American Chemical Society (NESACS).

12 Jan 2010

Alleged sex offender not a registered physiotherapist, confirms the College of Physiotherapists of Ontario

The College of Physiotherapists of Ontario, the organization entrusted by government and the public to regulate the over 7,000 physiotherapists in the province, was distressed to hear of the alleged abuse of a 15 year old female by an individual claiming to provide physiotherapy services. The College clarifies for the public that Sedat Ozdemir is not a registered physiotherapist in Ontario.

12 Jan 2010

First Edition: January 12, 2010

Today's news coverage details developments related to pending health reform plans with President Obama's meeting with organized labor regarding the 'Cadillac' tax claiming a lot of headlines.

12 Jan 2010

CBIZ acquires National Benefit Alliance

CBIZ, Inc. today announced the acquisition of National Benefit Alliance ("NBA"), an employee benefits firm located in Midvale, Utah, effective January 1, 2010.

12 Jan 2010

miRagen Therapeutics establishes SAB

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company’s world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.

12 Jan 2010

Medtech Investment Week to be held in Stockholm

On February 10-12th 2010, Medtech Investment Week is being held in Stockholm. The program features a tour of the Stockholm-Uppsala life science sector, providing a unique, exclusive and efficient opportunity to cover the latest news from one of the world’s leading medtech clusters.

12 Jan 2010

Criminal prosecution on Salmonella outbreak is yet to begin

Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.

12 Jan 2010

Attorney General to address "Cornhusker Kickback" provision in health care reform bill

South Carolina Attorney General Henry McMaster will discuss the review of state attorneys general into the constitutionality of the health care reform bill being considered by Congress, at a National Press Club Newsmaker press conference at 2:00 p.m. on Wednesday, January 13th, in the Zenger Room, 13th Floor, National Press Building, 529 14th Street, NW, Washington, DC.

12 Jan 2010

Quantros' application for fulfilling complex reporting requirements of MMSEA Section 111

Quantros announces the availability of MMSEA Manager, an application facilitating the online reporting of claims data required by CMS for Medicare clients who are part of a lawsuit and/or an ongoing medical payment or settlement. Testing and optional submission of MMSEA claim input files began January 1, 2010, with mandatory submission beginning April 1, 2010. The application is the latest addition to the Quantros Safety and Risk Management (SRM) product family.

12 Jan 2010

Nursing educators learn latest developments in nursing education at Faculty Development Institute conference

Nursing educators from across the country collaborated with industry leaders and learned the latest developments in nursing education at the 2010 Mosby's Faculty Development Institute conference earlier this month. Presented by Mosby, the three-day educational conference addressed challenges in the nursing industry from a variety of perspectives.

12 Jan 2010

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

Picis today announced that Frimley Park Hospital NHS Foundation Trust in Surrey, England has successfully implemented Picis integrated surgical, anesthesia, recovery room and critical care software solutions.

12 Jan 2010

FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system

Stereotaxis announced that the Celsius® RMT ThermoCool® catheter has been approved by the U.S. Food and Drug Administration for use with Stereotaxis' magnetic navigation system for the treatment of Type 1 atrial flutter. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for mapping and ablation.

12 Jan 2010

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).

12 Jan 2010

VentiRx Pharmaceuticals completes $25 million Series A Extension

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today the completion of a $25 million Series A Extension.

12 Jan 2010

Astro Pak announces the launch of new subsidiary, SixLog

Astro Pak Corporation, the U.S.'s largest precision cleaning and passivation company, today announced the launch of their new subsidiary, SixLog Corporation. SixLog provides on-site biological decontamination services utilizing proprietary iHP™ (ionized Hydrogen Peroxide) technology to a variety of industries including Life Sciences, Pharmaceutical, Healthcare, First Responders, Transportation, and Public Facilities.

12 Jan 2010

ePro custom footbeds reduce sport-induced injuries

eSoles® Custom Footbeds, the world's leading authority in the science and development of custom footbeds, announced today that eSoles Pro, Karlos Dansby, linebacker for the Arizona Cardinals® (#58), lead his team to a victory during their NFC Wild-Card playoff game while wearing his eSoles custom footbeds.

12 Jan 2010

MedGenesis Therapeutix enters into license agreement with Amgen

MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.

12 Jan 2010

Madison Williams launches Healthcare Investment Banking and Research business

Madison Williams and Company, an integrated capital markets and advisory firm, announced today the formal launch of a focused Healthcare Investment Banking and Research business. Madison Williams recently completed a management buyout of the principal capital markets business from Sanders Morris Harris Group in December 2009. The new firm already has a leading franchise in the Energy sector, and is quickly establishing its presence in healthcare with key new hires.

12 Jan 2010

Medical News

Increased doses of erlotinib drug may lead to better outcomes in lung cancer patients

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

Richard N. Zare to receive the 2010 TWR Medal for Conspicuous Achievement in Chemistry

Alleged sex offender not a registered physiotherapist, confirms the College of Physiotherapists of Ontario

First Edition: January 12, 2010

CBIZ acquires National Benefit Alliance

miRagen Therapeutics establishes SAB

Medtech Investment Week to be held in Stockholm

Criminal prosecution on Salmonella outbreak is yet to begin

Attorney General to address "Cornhusker Kickback" provision in health care reform bill

Quantros' application for fulfilling complex reporting requirements of MMSEA Section 111

Nursing educators learn latest developments in nursing education at Faculty Development Institute conference

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

VentiRx Pharmaceuticals completes $25 million Series A Extension

Astro Pak announces the launch of new subsidiary, SixLog

ePro custom footbeds reduce sport-induced injuries

MedGenesis Therapeutix enters into license agreement with Amgen

Madison Williams launches Healthcare Investment Banking and Research business

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News